US Patent 12110560 Methods for monitoring residual disease
Patent 12110560 was granted and assigned to Guardant Health on October, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 4, 2024
0
Date of Patent
October 8, 2024
0
Patent Applicant
Patent Application Number
18594336
0
Patent Citations
•••
Patent Inventor Names
AmirAli Talasaz
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent 12110560 Methods for monitoring residual disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
